1910 Genetics vs Synthace

<p>1910 Genetics is an AI-driven software platform that transforms drug discovery by combining massive multimodal data, advanced AI models, and high-throughput laboratory automation. It targets scientists, researchers, and biotech companies aiming to innovate therapeutics effectively. By leveraging its proprietary ITO™ platform and PEGASUS™ AI model, you can speed up the development of breakthrough small and large molecule drugs, including macrocyclic peptides.</p> <p>With 1910 Genetics, you get a cohesive environment that supports collaboration, molecular design, and data integration tailored for AI-enabled discovery. You can also engage in co-engineering services to build customized drug discovery modules using interactive tools such as dashboards and chatbots. This platform is designed to push innovation boundaries in biotech, helping you get drugs to market faster with more precision and efficiency.</p>

<p>Synthace is a software platform designed to help drug discovery teams accelerate assay development and scientific experimentation by automating complex, multifactorial experiments. It enables scientists to move faster and deliver more robust assays through an easy-to-use system integrated with existing lab equipment and expert support. You can scale digital experimentation methods across your organization with user-friendly tools and dedicated specialists who work closely with your team.</p> <p>With Synthace, you get a comprehensive solution combining software, training, and on-site support to cut down experimental timelines and gain reliable results. The platform supports multifactorial design of experiments and standardizes workflows to facilitate better go/no go decisions in drug discovery. It caters mainly to pharmaceutical and biotech research teams aiming to innovate and optimize assay development with higher throughput and efficiency.</p>